In light of our data regarding the effect of P53 in beta cells, we posit that the observed protection against diabetes after systemic Nutlin-3 treatment is mediated by P53 in non-beta cells [40], although differences in beta cell biology between rats and mice may also be relevant here. Here, TP53 is linked to diabetes mellitus.